These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12700300)

  • 1. The 12 year prognosis of unilateral functional weakness and sensory disturbance.
    Stone J; Sharpe M; Rothwell PM; Warlow CP
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):591-6. PubMed ID: 12700300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are functional motor and sensory symptoms really more frequent on the left? A systematic review.
    Stone J; Sharpe M; Carson A; Lewis SC; Thomas B; Goldbeck R; Warlow CP
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):578-81. PubMed ID: 12397155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional weakness and sensory loss.
    Lanska DJ
    Semin Neurol; 2006 Jul; 26(3):297-309. PubMed ID: 16791776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognosis of functional limb weakness: a 14-year case-control study.
    Gelauff JM; Carson A; Ludwig L; Tijssen MAJ; Stone J
    Brain; 2019 Jul; 142(7):2137-2148. PubMed ID: 31167232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The symptom of functional weakness: a controlled study of 107 patients.
    Stone J; Warlow C; Sharpe M
    Brain; 2010 May; 133(Pt 5):1537-51. PubMed ID: 20395262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional weakness and sensory disturbance.
    Stone J; Zeman A; Sharpe M
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):241-5. PubMed ID: 12185152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of 'positive' clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review.
    Daum C; Hubschmid M; Aybek S
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):180-90. PubMed ID: 23467417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor conversion disorders reviewed from a neuropsychiatric perspective.
    Krem MM
    J Clin Psychiatry; 2004 Jun; 65(6):783-90. PubMed ID: 15291655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term sensory deficit after Guillain-Barré syndrome.
    Bernsen RA; Jager AE; Schmitz PI; van der Meché FG
    J Neurol; 2001 Jun; 248(6):483-6. PubMed ID: 11499638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMRI in patients with motor conversion symptoms and controls with simulated weakness.
    Stone J; Zeman A; Simonotto E; Meyer M; Azuma R; Flett S; Sharpe M
    Psychosom Med; 2007 Dec; 69(9):961-9. PubMed ID: 17991812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?
    Stone J; Carson A; Duncan R; Coleman R; Roberts R; Warlow C; Hibberd C; Murray G; Cull R; Pelosi A; Cavanagh J; Matthews K; Goldbeck R; Smyth R; Walker J; Macmahon AD; Sharpe M
    Brain; 2009 Oct; 132(Pt 10):2878-88. PubMed ID: 19737842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver agreement and validity of bedside 'positive signs' for functional weakness, sensory and gait disorders in conversion disorder: a pilot study.
    Daum C; Gheorghita F; Spatola M; Stojanova V; Medlin F; Vingerhoets F; Berney A; Gholam-Rezaee M; Maccaferri GE; Hubschmid M; Aybek S
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):425-30. PubMed ID: 24994927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
    Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
    Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional sensory symptoms.
    Stone J; Vermeulen M
    Handb Clin Neurol; 2016; 139():271-281. PubMed ID: 27719847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensory loss in hospital-admitted people with stroke: characteristics, associated factors, and relationship with function.
    Tyson SF; Hanley M; Chillala J; Selley AB; Tallis RC
    Neurorehabil Neural Repair; 2008; 22(2):166-72. PubMed ID: 17687023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.
    Paik JJ; Wigley FM; Mejia AF; Hummers LK
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1695-1703. PubMed ID: 26881982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cauda equina syndrome: factors affecting long-term functional and sphincteric outcome.
    McCarthy MJ; Aylott CE; Grevitt MP; Hegarty J
    Spine (Phila Pa 1976); 2007 Jan; 32(2):207-16. PubMed ID: 17224816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
    Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
    Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study.
    Duyff RF; Van den Bosch J; Laman DM; van Loon BJ; Linssen WH
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):750-5. PubMed ID: 10811699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.